From: HCV infection characteristics, treatment uptake and outcomes in patient with diabetes mellitus
Effect | Unadjusted OR, 95% CI | Adjusted OR, 95% CI |
---|---|---|
DM diagnosis | 1.09 (1.05-3.47) | 1.37 (0.54-3.46) |
Age at first assessment | 1.03 (1.02-1.05) | 1.02 (1.01-1.05) |
Male sex | 0.82 (0.57-1.18) | 1.54 (1.33-2.72) |
Genotype | ||
 G1 | 0.65 (0.32-1.35) | 1.48 (0.58-3.79) |
 G2 | 0.64 (0.25-1.66) | 1.43 (0.78-2.61) |
 G3 | 0.51 (0.24-1.12) | 0.38 (0.09-1.70) |
 Other | Ref. | Ref. |
Cirrhosis by FibroScana | 1.17 (0.79-1.72) | 1.40 (0.71-2.76) |
Steatosis by Fibroscanb | 1.26 (0.71-2.23) | 1.44 (0.74-2.80) |
Race | ||
 Caucasian | 1.14 (0.78-1.67) | 0.74 (0.34-1.62) |
 Non-Caucasian | Ref. | Ref. |
HIV co-infection | 1.15 (0.48-2.88) | 1.49 (0.48-4.65) |
Psychiatric illness | 0.95 (0.68-1.33) | 0.59 (0.33-1.04) |
Hepatocellular carcinoma | 0.86 (0.37-2.00) | 1.05 (0.13-8.74) |
Currently employed | 2.24 (1.32-3.81) | 2.10 (1.06-4.15) |
History of alcohol use | 0.77 (0.54-1.11) | 1.17 (0.66-2.09) |
Incarceration history | 0.77 (0.54-1.11) | 0.56 (0.31-1.03) |
IDU history | 0.70 (0.48-1.03) | 0.55 (0.28-1.10) |